Loading clinical trials...
Loading clinical trials...
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)
Conditions
Interventions
SF0166 Topical Ophthalmic Solution
Locations
12
United States
Retinal Research Institute LLC
Phoenix, Arizona, United States
Retina Consultants of Orange County
Fullerton, California, United States
Northern California Retina Vitreous Associates Medical Group, Inc
Mountain View, California, United States
Retina Macula Specialists of Miami, LLC
Miami, Florida, United States
Center for Retina and Macular Disease
Winter Haven, Florida, United States
John Kenyon Eye Institute
New Albany, Indiana, United States
Start Date
October 5, 2016
Primary Completion Date
June 26, 2017
Completion Date
June 26, 2017
Last Updated
June 7, 2023
NCT05913063
NCT07392255
NCT06990269
NCT06970665
NCT07160179
NCT06557460
Lead Sponsor
OcuTerra Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions